Kwality Pharmaceuticals Limited Financial Ratios
KPL · Healthcare · Current price ₹3,370
P/E ratio
51.9x
P/B ratio
8.6x
ROE
22.6%
ROCE
24.0%
Debt / Equity
0.39
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 51.9x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 8.6x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 22.6% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 24.0% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.39 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Kwality Pharmaceuticals Limited's latest numbers.
Kwality Pharmaceuticals Limited profitability
Kwality Pharmaceuticals Limited generates a return on equity of 22.6% and a return on capital employed of 24.0%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.39 and a P/E of 51.9x, Kwality Pharmaceuticals Limited is conservatively financed. Our overall business-quality score for the company is 5.8 / 10.
Understand the ratios
More on Kwality Pharmaceuticals Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.